HCP no longer a Buy at Jefferies

• Saying rent coverage in the HCR Manor Care portfolio is unlikely to improve in the near future and acquisition volumes remain weak, Jefferies cashes in its chips on its Buy call for HCP, cutting to Hold with price target lowered to $45 from $47.
• The stock's higher by 18% YTD.